USPTO serial 79381674
MIYÉ WOMEN'S BODY ECOLOGY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 21, 2025
- Examiner
- JANSON, ANDREW KYLE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MIYÉ WOMEN'S BODY ECOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew N. Spivak
Andrew N. Spivak Mosaic Legal Group, PLLC4300 Fordham Road, NW, Suite 250Washington, DC 20016-1950United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated soaps; Soap-free washing emulsions for the body; Non-medicated skin care preparations in the nature of body mist; Shower gels for the body; Body massage oils; Massage gels, other than for medical purposes; Non-medicated skin care preparations for the body care; Non-medicated skin care preparations; Cosmetics; Hair lotions; Non-medicated anti-hair-loss serums; Hair care preparations and treatments for cosmetic purposes; Shampoos; Make-up remover; Beauty masks; Non-medicated cleansers for intimate personal hygiene purposes; Washes or deodorants for intimate personal hygiene purposes; Non-medicated shower body oils; Facial massage oils; Face oils; Cleaning beauty masks for the face | ACTIVE | — |
| 005 | Pharmaceuticals products for the treatment of female hormonal imbalances suffered during different phases of life, including premenstrual syndrome, endometriosis, polycystic ovary syndrome, pregnancy, post-partum, pre-menopause, menopause, and the prevention of related symptoms, including abdominal pain, hot flushes, mood and sleep variations, intimate dryness, hormonal acne, hair loss, breast pain, water retention and bloating; Food supplements for human consumption for non-medical use; Food supplements containing vitamins; Vitamin supplements; Vitamin supplements in tablet form; Vitamin drops; Vitamin and mineral supplements; Antioxidants being food supplements; Medicated balms for for the treatment of female hormonal imbalances suffered during different phases of life, including premenstrual syndrome, endometriosis, polycystic ovary syndrome, pregnancy, post-partum, pre-menopause, menopause, and the prevention of related symptoms, including abdominal pain, hot flushes, mood and sleep variations, intimate dryness, hormonal acne, hair loss, breast pain, water retention and bloating; Medicated skin care oils, other than essential oils, containing vitamins, minerals, essential fats, excipients and active ingredients derived from green biotechnology ; Hygienic products for medical use, namely, disinfectants for hygienic purposes; Preparations based on trace elements for human use, namely, medical preparations for the treatment of female hormonal imbalances suffered during different phases of life, including premenstrual syndrome, endometriosis, polycystic ovary syndrome, pregnancy, post-partum, pre-menopause, menopause, and the prevention of related symptoms, including abdominal pain, hot flushes, mood and sleep variations, intimate dryness, hormonal acne, hair loss, breast pain, water retention and bloating, containing Calcium, Chlorine, Chromium, Copper, Iron, Iodine, Magnesium, Manganese, Molybdenum, Phosphorus, Potassium, Selenium, Sodium and Zinc ; Biological preparations for medical use for the treatment of female hormonal imbalances suffered during different phases of life, including premenstrual syndrome, endometriosis, polycystic ovary syndrome, pregnancy, post-partum, pre-menopause, menopause, and the prevention of related symptoms, including abdominal pain, hot flushes, mood and sleep variations, intimate dryness, hormonal acne, hair loss, breast pain, water retention and bloating; Medicinal healthcare preparations for the treatment of female hormonal imbalances suffered during different phases of life, including premenstrual syndrome, endometriosis, polycystic ovary syndrome, pregnancy, post-partum, pre-menopause, menopause, and the prevention of related symptoms, including abdominal pain, hot flushes, mood and sleep variations, intimate dryness, hormonal acne, hair loss, breast pain, water retention and bloating ; Medicated skin soothing serum; Medicated anti-hair-loss hair serums; Medicinal herb teas; Medicinal tea; Dietetic infusions for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 22, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 3, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 3, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 21, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 25, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 24, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 16, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 16, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 4, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |